About this trial
The aim of this study is to characterize patients in the Post-Intensive-Care-Syndrome (PICS) outpatient clinic based on routine data and to evaluate their treatment outcome over the course of their treatment. For this purpose, data sets from approx. 40 patients who were treated in the intensive care unit subsequently evaluated in the PICS outpatient clinic between March 27, 2020, and May 6, 2024, will be analyzed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: 18 years and older
Admission to a Charité intensive care unit and follow-up examination by the Post-Intensive-Care-Syndrome (PICS) outpatient clinic of the Department of Anesthesiology and Intensive Care Medicine between March 27, 2020 and May 6, 2024.
COVID-19 infection in temporal assocoation with the intensive care unit admission.
Intensive care unit admission with lung failure or development of lung failure in the course of intensive care unit treatment.
Disqualifiers
Gender: Male
Diagnosis: Non-COVID or no respiratory failure
Trial population
Adult female pregnant and non-pregnant patients who were admitted to a Charité intensive care unit and follow-up examination by the Post-Intensive-Care-Syndrome (PICS) outpatient clinic of the Department of Anesthesiology and Intensive Care Medicine, Charité - Universitaetsmedizin Berlin between March 27, 2020 and May 6, 2024.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Impairment in at least one PICS domain (mobility, cognition, and/or mental health)
Impairment in at least one PICS domain (mobility, cognition, and/or mental health) after discharge from the ICU, assessed at the time of presentation to the PICS outpatient clinic. The planned PICS outpatient presentation takes place 3 and 6 months (ranging from 1 month to 3 years) after the initial ICU stay.
Secondary outcomes
Catecholamine therapy
Catecholamine therapy during intensive care unit (ICU) treatment is measured in doses and duration.
Extracorporeal Membrane Oxygenation treatment
Extracorporeal Membrane Oxygenation treatment in the ICU Yes or No
Need for ventilation during ICU treatment
Need for ventilation during ICU treatment and, if so, ventilation route (non-invasive and invasive, endotracheal tube and tracheostomy tube) and duration of ventilation
Duration of ventilation during ICU treatment
Duration of ventilation during ICU treatment is measured in hours
Sponsors and contacts
Click on the lead sponsor to view all of their trials.